Malignant Hypertension Without End-Organ Damage Secondary to Stressful Condition in a Female

被引:2
作者
Hussain, Hussain [1 ]
Fadel, Aya [2 ]
机构
[1] Cardiol Clin, Internal Med, Pasadena, CA 91105 USA
[2] Florida Int Univ, Hialeah Hosp, Internal Med, Miami, FL 33199 USA
关键词
malignant hypertension; hypertensive emergency; physiological changes in stress; hypertension; catecholamines;
D O I
10.7759/cureus.10109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malignant hypertension (hypertensive emergency), is an extreme elevation of blood pressure under certain conditions that can lead to organ damage and other serious consequences. It is a common condition that affects about one in three Americans, according to the Centers for Disease Control and Prevention. An elevation of systolic blood pressure above 180 mmHg and diastolic blood pressure above 120 mmHg is considered a hypertensive emergency. This article addresses the case of a 61-year-old female patient who presented to the ER with a semicomatose and gasping condition and response to painful stimuli with an unclear voice. She also had unstable vital signs, with a blood pressure of 370/200 mmHg, a pulse rate of 115, a respiratory rate of 22, and a pulse oximetry of 96%, but no fever. Her son provided a brief history and reported that a stressful condition had occurred at home one hour before; she had begun to scream and been brought to the ER by ambulance in the condition described above. Cardiac monitoring and an electrocardiograph were performed and indicated a normal condition besides the unstable vital signs. Oxygen was administered via a nasal cannula with 20 mg of intravenous hydralazine, and the patient's blood pressure improved progressively. Moreover, she regained consciousness with no end-organ damage. A hypertensive emergency is usually associated with end-organ damage, such as heart, kidney, eye, or brain damage. However, in this case, despite the extreme elevation of her blood pressure, the patient suffered no organ damage. It is essential to manage the extreme elevation of blood pressure as soon as possible and monitor the patient for consequences.
引用
收藏
页数:10
相关论文
共 50 条
[41]   Role of the Anaphylatoxin Receptor C5aR2 in Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage [J].
Dreher, Leonie ;
Bode, Marlies ;
Ehnert, Nicolas ;
Meyer-Schwesinger, Catherine ;
Wiech, Thorsten ;
Koehl, Joerg ;
Huber, Tobias B. ;
Freiwald, Tilo ;
Herrnstadt, Georg R. ;
Wenzel, Ulrich O. .
AMERICAN JOURNAL OF HYPERTENSION, 2024, 37 (10) :810-825
[42]   p38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1 [J].
Nerurkar, S. S. ;
Olzinski, A. R. ;
Frazier, K. S. ;
Mirabile, R. C. ;
O'Brien, S. P. ;
Jing, J. ;
Rajagopalan, D. ;
Yue, T. -L. ;
Willette, R. N. .
BIOMARKERS, 2007, 12 (01) :87-112
[43]   Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats [J].
Liu, JG ;
Xu, LP ;
Chu, ZX ;
Miao, CY ;
Su, DF .
JOURNAL OF HYPERTENSION, 2003, 21 (10) :1961-1967
[44]   Integrin-linked kinase: a new member of the kinases involved in hypertensive end-organ damage? [J].
Obama, Takashi ;
Eguchi, Satoru .
CLINICAL SCIENCE, 2014, 127 (1-2) :15-17
[45]   A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure [J].
Aubdool, Aisah A. ;
Thakore, Pratish ;
Argunhan, Fulye ;
Smillie, Sarah-Jane ;
Schnelle, Moritz ;
Srivastava, Salil ;
Alawi, Khadija M. ;
Wilde, Elena ;
Mitchell, Jennifer ;
Farrell-Dillon, Keith ;
Richards, Daniel A. ;
Maltese, Giuseppe ;
Siow, Richard C. ;
Nandi, Manasi ;
Clark, James E. ;
Shah, Ajay M. ;
Sams, Anette ;
Brain, Susan D. .
CIRCULATION, 2017, 136 (04) :367-+
[46]   LONG TERM END-ORGAN INFLAMMATION AND DYSFUNCTION IN MICE AFTER ANGIOTENSIN II-INDUCED HYPERTENSION [J].
Chen, Wei ;
Xiao, Liang ;
Harrison, David .
JOURNAL OF HYPERTENSION, 2018, 36 :E85-E85
[47]   Prevalence of Microalbuminuria in Hypertension Patients and Its Correlation with the Severity of Hypertension and End Organ Damage [J].
Pudota, Papaiah Nirmal ;
Vedamanickam, R. .
JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2021, 9 (05) :227-233
[48]   End-organ protection in hypertension by the novel and selective Rho-kinase inhibitor, SAR407899 [J].
Loehn, Matthias ;
Plettenburg, Oliver ;
Kannt, Aimo ;
Kohlmann, Markus ;
Hofmeister, Armin ;
Kadereit, Dieter ;
Monecke, Peter ;
Schiffer, Alexander ;
Schulte, Anke ;
Ruetten, Hartmut ;
Ivashchenko, Yuri .
WORLD JOURNAL OF CARDIOLOGY, 2015, 7 (01) :31-42
[49]   Atorvastatin prevents end-organ injury in salt-sensitive hypertension - Role of eNOS and oxidant stress [J].
Zhou, MS ;
Jaimes, EA ;
Raij, L .
HYPERTENSION, 2004, 44 (02) :186-190
[50]   Exploring the Link Between Cardiovascular Reactivity and End-Organ Damage in African and Caucasian Men: The SABPA Study [J].
Huisman, Hugo W. ;
Schutte, Aletta E. ;
Schutte, Rudolph ;
van Rooyen, Johannes M. ;
Fourie, Carla M. T. ;
Mels, Catharina M. C. ;
Smith, Wayne ;
Malan, Nicolaas T. ;
Malan, Leone .
AMERICAN JOURNAL OF HYPERTENSION, 2013, 26 (01) :68-75